Disclosures for "Disease-modifying Therapy Discontinuation and Outcomes of Older People with Multiple Sclerosis (MS) at a Large Academic MS Center in Toronto, Canada"
-
Ms. Tsai has received research support from Foundation of the Consortium of Multiple Sclerosis Centers. Ms. Tsai has received research support from UBC Multiple Sclerosis Connect Program.
-
Ms. Raufdeen has nothing to disclose.
-
Dr. Schneider has nothing to disclose.
-
Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis.
-
Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.